Page 3 - Clinical Sciences News Today

Enhertu lengthened the time to progression in patients with HR-positive, HER2-low or -ultralow metastatic breast cancer.

Researchers analyzed multi-omic data from 231 people with PTSD or depression to uncover distinct molecular differences that might affect systems such as the nervous and immune systems, to contribute to these mental health conditions.

A comprehensive approach that examines the intersection of multiple biological processes is necessary to elucidate the development of stress-related disorders. In a new study, investigators from McLean Hospital, a member of the Mass General Brigham health care system, working with colleagues at The University of Texas at Austin and Lieber Institute for Brain Development, uncovered both shared and distinct molecular changes across brain regions, genomic layers, cell types, and blood in individual...

The podcast by pharmacists, for pharmacists, brought to you by the AJP. Each episode, join a diverse panel of pharmacists from all settings and experience levels discussing topics that affect pharmacists in day to day practice.

Patrick Ott, MD, PhD, discusses the investigation of cancer vaccines, highlighting the clinical implications of this treatment modality in melanoma.

A collaborative academic research programme, Hypertension Treatment in Nigeria, which has enrolled over 23,000 patients with hypertension, is seeking to scale up its work to five new states in the country. Co-Principal Investigator, Hypertension Treatment in Nigeria Programme, Professor Mark Huffman of Washington University in St. Louis, USA and Dike…

The College of Medicine, University of Lagos, has advised its newly inducted nursing science students to make integrity, and trustworthiness their watchwords.

A groundbreaking gene therapy at Umeå University displays remarkable efficacy in decelerating the advancement of ALS in a patient with a severe form of the disease.

ISTANBUL--(BUSINESS WIRE)--Apr 19, 2024--

Researchers conducted a large trial to determine whether beta-blockers provide benefits in people with preserved ejection fraction after a myocardial infarction (heart attack). The findings show that beta-blockers had no significant benefit following a heart attack in people with normal heart function.